Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023

BUY
$10.75 - $29.84 $34,980 - $97,099
3,254 Added 26.63%
15,473 $190,000
Q3 2022

Nov 08, 2022

BUY
$19.9 - $38.94 $52,575 - $102,879
2,642 Added 27.59%
12,219 $401,000
Q2 2022

Aug 04, 2022

BUY
$13.67 - $25.74 $1,052 - $1,981
77 Added 0.81%
9,577 $180,000
Q1 2022

May 05, 2022

BUY
$14.13 - $28.49 $134,235 - $270,655
9,500 New
9,500 $167,000

Others Institutions Holding CINC

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About CinCor Pharma, Inc.


  • Ticker CINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,764,300
  • Description
  • CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...
More about CINC
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.